Cargando…
389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children
BACKGROUND: During the earlier phase of the COVID-19 pandemic, published reports demonstrated low rates of COVID co-viral infections. Upon relaxing public health measures, the epidemiology of known respiratory viral pathogens had dramatically shifted as the pandemic evolved. Little is known about th...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678413/ http://dx.doi.org/10.1093/ofid/ofad500.459 |
_version_ | 1785150355574620160 |
---|---|
author | Anosike, Brenda I Sharma, Shiv M Sarill, Kiera Alrikaby, Jassour Duong, Tim Q Herold, Betsy |
author_facet | Anosike, Brenda I Sharma, Shiv M Sarill, Kiera Alrikaby, Jassour Duong, Tim Q Herold, Betsy |
author_sort | Anosike, Brenda I |
collection | PubMed |
description | BACKGROUND: During the earlier phase of the COVID-19 pandemic, published reports demonstrated low rates of COVID co-viral infections. Upon relaxing public health measures, the epidemiology of known respiratory viral pathogens had dramatically shifted as the pandemic evolved. Little is known about the clinical impact of co-viral infections in children post-Omicron wave. This study investigates the clinical outcomes among children, adolescents, and young adults who test positive for SARS-CoV-2 [COVID] alone compared to those with COVID co-viral infection with either RSV or Influenza [Flu] A/B [denoted as COVID+] METHODS: We conducted a retrospective study of subjects ≤ 21 years of age who tested positive for SAR-CoV-2 presenting to the Children’s Hospital at Montefiore, Bronx, NY from 12/1/2021 to 1/15/2023. Laboratory confirmation was established using a multi-target PCR assay for influenza A/B, RSV, and SARS-CoV-2. The primary outcomes were hospitalization, need for invasive mechanical ventilation (IMV), and mortality. Demographic and patient outcomes were extracted using ATLAS database. RESULTS: Among 8307 subjects who tested positive for COVID alone, 8.5% (708) were hospitalized with a mean age of 8.7 years (SD=7.8) while mean age of those with COVID+ was 5.0 years (SD=4.4). Hospitalization rates for COVID alone, COVID+Flu, and COVID+RSV were 6.4%, 32.2%, and 57.7%, respectively (p< 0.001). COVID positive children ≤ 5 years of age with or without a second virus were more likely to be hospitalized than other age group (p< 0.001). When comparing COVID+Flu vs. Flu alone (32.2% vs. 4.3%, p< 0.001) or COVID+RSV vs. RSV alone (57.7% vs. 15.8%, p< 0.001), hospitalization rates were higher for those with COVID co-viral infections. No increase in mortality was observed. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: This single center retrospective study demonstrates that SARS-CoV-2 coinfection with RSV or Influenza is associated with increased risk for hospitalization compared to SARS-CoV-2, RSV or influenza alone. Hospitalization rates were higher in younger children. Further studies are needed to identify the mechanisms driving the increased morbidity associated with these coinfections. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-10678413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106784132023-11-27 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children Anosike, Brenda I Sharma, Shiv M Sarill, Kiera Alrikaby, Jassour Duong, Tim Q Herold, Betsy Open Forum Infect Dis Abstract BACKGROUND: During the earlier phase of the COVID-19 pandemic, published reports demonstrated low rates of COVID co-viral infections. Upon relaxing public health measures, the epidemiology of known respiratory viral pathogens had dramatically shifted as the pandemic evolved. Little is known about the clinical impact of co-viral infections in children post-Omicron wave. This study investigates the clinical outcomes among children, adolescents, and young adults who test positive for SARS-CoV-2 [COVID] alone compared to those with COVID co-viral infection with either RSV or Influenza [Flu] A/B [denoted as COVID+] METHODS: We conducted a retrospective study of subjects ≤ 21 years of age who tested positive for SAR-CoV-2 presenting to the Children’s Hospital at Montefiore, Bronx, NY from 12/1/2021 to 1/15/2023. Laboratory confirmation was established using a multi-target PCR assay for influenza A/B, RSV, and SARS-CoV-2. The primary outcomes were hospitalization, need for invasive mechanical ventilation (IMV), and mortality. Demographic and patient outcomes were extracted using ATLAS database. RESULTS: Among 8307 subjects who tested positive for COVID alone, 8.5% (708) were hospitalized with a mean age of 8.7 years (SD=7.8) while mean age of those with COVID+ was 5.0 years (SD=4.4). Hospitalization rates for COVID alone, COVID+Flu, and COVID+RSV were 6.4%, 32.2%, and 57.7%, respectively (p< 0.001). COVID positive children ≤ 5 years of age with or without a second virus were more likely to be hospitalized than other age group (p< 0.001). When comparing COVID+Flu vs. Flu alone (32.2% vs. 4.3%, p< 0.001) or COVID+RSV vs. RSV alone (57.7% vs. 15.8%, p< 0.001), hospitalization rates were higher for those with COVID co-viral infections. No increase in mortality was observed. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: This single center retrospective study demonstrates that SARS-CoV-2 coinfection with RSV or Influenza is associated with increased risk for hospitalization compared to SARS-CoV-2, RSV or influenza alone. Hospitalization rates were higher in younger children. Further studies are needed to identify the mechanisms driving the increased morbidity associated with these coinfections. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678413/ http://dx.doi.org/10.1093/ofid/ofad500.459 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Anosike, Brenda I Sharma, Shiv M Sarill, Kiera Alrikaby, Jassour Duong, Tim Q Herold, Betsy 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children |
title | 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children |
title_full | 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children |
title_fullStr | 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children |
title_full_unstemmed | 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children |
title_short | 389. PediCoViral: Clinical Outcomes of COVID-related Co-viral infections in Children |
title_sort | 389. pedicoviral: clinical outcomes of covid-related co-viral infections in children |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678413/ http://dx.doi.org/10.1093/ofid/ofad500.459 |
work_keys_str_mv | AT anosikebrendai 389pedicoviralclinicaloutcomesofcovidrelatedcoviralinfectionsinchildren AT sharmashivm 389pedicoviralclinicaloutcomesofcovidrelatedcoviralinfectionsinchildren AT sarillkiera 389pedicoviralclinicaloutcomesofcovidrelatedcoviralinfectionsinchildren AT alrikabyjassour 389pedicoviralclinicaloutcomesofcovidrelatedcoviralinfectionsinchildren AT duongtimq 389pedicoviralclinicaloutcomesofcovidrelatedcoviralinfectionsinchildren AT heroldbetsy 389pedicoviralclinicaloutcomesofcovidrelatedcoviralinfectionsinchildren |